For instance, the abnormal activation of the Jun N-terminal kinases signaling pathway, one of the MAPK signaling pathways, has been reported in ovarian cancer frequently, making it one of the most important signaling pathways in the treatment of ovarian cancer [14–17]. This evidence concerns the gene MAPK8 and ovarian carcinoma.